Wai, Bryan <br/><br/>
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.  [electronic resource] 

 -  Cardiovascular diabetology  Feb 2012 
 - 14 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1475-2840 
<br/><br/><label>Standard No.: </label>10.1186/1475-2840-11-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Aged<br/>Aged, 80 and over<br/>Albuminuria--etiology<br/>Biomarkers--blood<br/>Bisoprolol--therapeutic use<br/>Carbazoles--therapeutic use<br/>Carvedilol<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Nephropathies--etiology<br/>Female<br/>Glomerular Filtration Rate--drug effects<br/>Glycated Hemoglobin--metabolism<br/>Heart Failure, Systolic--complications<br/>Hospitals, Teaching<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Propanolamines--therapeutic use<br/>Prospective Studies<br/>Time Factors<br/>Treatment Outcome<br/>Victoria